Title : Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-α agent with a disease-modifying antirheumatic drug?

Pub. Date : 2014 Jun

PMID : 27708877






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-alpha agent with a disease-modifying antirheumatic drug? Isoniazid tumor necrosis factor Homo sapiens
2 OBJECTIVE: The aim of this study is to determine the incidence of isoniazid (INH)-related hepatotoxicity in patients with rheumatologic diseases receiving tumor necrosis factor-alpha (TNF-alpha) antagonists along with a disease-modifying antirheumatic drug (DMARD). Isoniazid tumor necrosis factor Homo sapiens
3 OBJECTIVE: The aim of this study is to determine the incidence of isoniazid (INH)-related hepatotoxicity in patients with rheumatologic diseases receiving tumor necrosis factor-alpha (TNF-alpha) antagonists along with a disease-modifying antirheumatic drug (DMARD). Isoniazid tumor necrosis factor Homo sapiens